Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 17.39% ...
Molecular Templates is a clinical-stage biopharmaceutical company focused on the discovery and development of next-generation ADCs. Its drug platform technology, known as Engineered Toxin Bodies (ETBs ...
Compliancy Group is also in the Healthcare Risk Management category, rated as number one for templates, education, incident management, report generation, and user satisfaction. Solve healthcare ...